Skandinaviska Enskilda Banken Ab (Publ) Bei Gene, Ltd. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$215.53 - $274.5 $531,712 - $677,191	-2,467 Reduced 47.64%	2,711 $584,000
Q4 2022 Feb 08, 2023	SELL	$125.51 - $229.3 $665,077 - $1.22 Million	-5,299 Reduced 50.58%	5,178 $1.14 Million
Q1 2022 May 11, 2022	SELL	$146.52 - $269.56 $124,835 - $229,665	-852 Reduced 7.52%	10,477 $1.98 Million
Q3 2021 Nov 10, 2021	SELL	$249.6 - $403.14 $999,148 - $1.61 Million	-4,003 Reduced 26.11%	11,329 $4.11 Million
Q2 2021 Aug 10, 2021	BUY	$292.75 - $367.01 $1.23 Million - $1.54 Million	4,196 Added 37.68%	15,332 $5.26 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $1.18 Million - $1.73 Million	4,536 Added 68.73%	11,136 $3.88 Million
Q4 2020 Feb 11, 2021	BUY	$221.31 - $316.61 $287,703 - $411,593	1,300 Added 24.53%	6,600 $1.71 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $18,918 - $28,644	100 Added 1.92%	5,300 $1.52 Million
Q1 2020 Jun 05, 2020	BUY	$121.84 - $173.19 $633,568 - $900,588	5,200 New	5,200 $640,000
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $609,200 - $865,950	-5,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $344,098 - $619,186	2,972 Added 146.55%	5,000 $829,000
Q3 2019 Nov 08, 2019	BUY	$120.61 - $148.29 $48,244 - $59,316	400 Added 24.57%	2,028 $248,000
Q2 2019 Aug 09, 2019	BUY	$113.99 - $146.86 $185,575 - $239,088	1,628 New	1,628 $202,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.